| 2007 |
FANCI is monoubiquitinated on a specific lysine residue and forms a heterodimeric complex with FANCD2 (the ID complex) that localizes to chromatin in response to DNA damage. Ubiquitination of each protein is required for maintenance of ubiquitin on the other, indicating a dual ubiquitin-locking mechanism. |
Co-immunoprecipitation, Western blot, chromatin fractionation, cell-based complementation assays |
Cell |
High |
17412408
|
| 2007 |
FANCI is a second monoubiquitinated component of the FA pathway; biallelic mutations in FANCI cause Fanconi anemia complementation group I. |
Sequence homology search, mutation analysis, biochemical validation |
Nature structural & molecular biology |
High |
17460694
|
| 2008 |
ATR/ATM-mediated phosphorylation of multiple conserved Ser/Thr-Gln (SQ/TQ) motifs on FANCI serves as a molecular switch to activate the FA pathway, promoting monoubiquitination of both FANCI and FANCD2 and their focus formation. Phosphomimetic FANCI constitutively activates the pathway; phosphodead FANCI abrogates it. |
Alanine/phosphomimetic substitution mutagenesis in chicken DT40 cells, immunofluorescence, survival assays, chromosome breakage assays |
Nature structural & molecular biology |
High |
18931676
|
| 2008 |
FANCI protein enhances monoubiquitination of FANCD2 by the Ube2t-FANCL pair and restricts ubiquitination to the correct in vivo substrate lysine residue on FANCD2, establishing FANCI's role in site-restricted monoubiquitination. |
In vitro reconstitution of monoubiquitination with purified Ube2t, FANCL, and FANCI; mutational analysis |
Molecular cell |
High |
19111657
|
| 2009 |
FANCI directly binds DNA with preference for branched structures; the DNA binding domain encompasses residues 200–1000. FANCI is monoubiquitinated on Lys-523 by the UBE2T-FANCL pair in vitro. FANCI interacts with FANCD2 through its C-terminal fragment (residues 1001–1328), and the FANCI-FANCD2 complex shows enhanced preference for branched DNA structures compared to either protein alone. |
In vitro DNA binding assays with purified protein, in vitro ubiquitination assay, co-immunoprecipitation with purified proteins, truncation and point mutation analysis |
The Journal of biological chemistry |
High |
19561358 19589784
|
| 2009 |
Purified FANCI-FANCD2 complex preferentially binds branched DNA structures; FANCI interacts with FANCD2 through its C-terminal domain; two C-terminal patient-derived point mutations (R1285Q, D1301A) show altered DNA binding activity. |
Purified protein DNA binding assays, co-immunoprecipitation with purified proteins, truncation/point mutation analysis, immunofluorescence |
The Journal of biological chemistry |
High |
19561358
|
| 2010 |
Mono-ubiquitinated FANCI-FANCD2 (ID) complex recruits FAN1 nuclease to sites of DNA damage to facilitate ICL repair; FAN1 recruitment strictly depends on monoubiquitination of the ID complex. |
Co-immunoprecipitation, chromatin fractionation, siRNA knockdown, cell-based ICL sensitivity assays |
Science |
High |
20671156
|
| 2011 |
Crystal structure of the ~300 kDa FANCI-FANCD2 (ID) complex at 3.4 Å reveals that monoubiquitination and regulatory phosphorylation sites map to the I-D interface, suggesting these modifications occur on monomeric or opened-up complex and stabilize heterodimerization. Each protein has binding sites for both single- and double-stranded DNA. |
X-ray crystallography (3.4 Å crystal structure of ID complex; 7.8 Å electron density map of FANCI-DNA), in vitro DNA binding assays |
Science |
High |
21764741
|
| 2011 |
RAD18 E3 ubiquitin ligase binds FANCD2 and is required for efficient monoubiquitination and chromatin localization of both FANCD2 and FANCI; the RING domain of RAD18 is required for this interaction and chromatin loading. |
Co-immunoprecipitation, chromatin fractionation, RAD18 knockout cells, RING domain mutation, immunofluorescence |
Blood |
Medium |
21355096
|
| 2012 |
FANCD2 possesses nucleosome-assembly (histone chaperone) activity in vitro; FANCI alone lacks this activity but significantly stimulates FANCD2-mediated nucleosome assembly. FANCD2 mutations defective in nucleosome assembly impair cell survival after ICL damage. |
In vitro nucleosome assembly assay, histone mobility assays, FANCD2 knockdown, cisplatin sensitivity assays |
The EMBO journal |
Medium |
22828868
|
| 2012 |
DNA (single-stranded, double-stranded, and branched forms) robustly stimulates FANCD2 monoubiquitination in vitro in a manner strictly requiring FANCI. A FANCI mutant defective in DNA binding is also defective in stimulating FANCD2 monoubiquitination, linking FANCI DNA binding to ubiquitination efficiency. |
In vitro reconstituted monoubiquitination assay with purified components and various DNA substrates; FANCI DNA-binding mutant analysis |
Nucleic acids research |
High |
22287633
|
| 2012 |
FANCI phosphorylation by ATR is the molecular trigger for FANCD2-FANCI dissociation during DNA repair; phosphodead FANCI fails to dissociate from FANCD2, while phosphomimetic FANCI cannot interact with FANCD2. After dissociation, FANCD2 binds chromatin prior to and independently of FANCI. |
Phosphodead/phosphomimetic FANCI mutant analysis, co-immunoprecipitation, chromatin fractionation, cell-cycle analysis |
Nucleic acids research |
Medium |
22753026
|
| 2013 |
FANCD2 regulates BLM complex (BLMcx) functions independently of FANCI: FANCD2 maintains BLM protein stability, recruits BLMcx to chromatin, and cooperates with BLM to promote replication fork restart. FANCI is dispensable for FANCD2-dependent BLMcx regulation, demonstrating functional separation. |
siRNA knockdown, co-immunoprecipitation, chromatin fractionation, DNA fiber assays, replication origin firing assays |
Nucleic acids research |
Medium |
23658231
|
| 2013 |
Nuclear localization of a subset of FANCI depends on intact FANCD2 via an N-terminal FANCD2 nuclear localization signal; FANCD2 NLS mutation impairs both FANCD2 and FANCI nuclear localization, their monoubiquitination, and chromatin loading, resulting in ICL sensitivity. |
GFP fusion localization, NLS mutant analysis, Western blot, chromatin fractionation, ICL sensitivity complementation assays |
PloS one |
Medium |
24278431
|
| 2014 |
FANCD2 monoubiquitination within the ID2 complex is strongly stimulated by duplex or branched DNA but not by unstructured single-stranded DNA; FANCI mutations that impair DNA binding compromise DNA-stimulated FANCD2 monoubiquitination. In the absence of FANCD2, DNA also stimulates FANCI monoubiquitination in a FANCL-independent manner. |
In vitro reconstituted monoubiquitination assay with UBE2T and FANCL, various DNA substrates, FANCI DNA-binding mutants |
Nucleic acids research |
High |
24623813
|
| 2015 |
ATR-mediated phosphorylation of FANCI inhibits dormant origin firing while promoting replication fork restart/DNA repair. FANCI co-localizes with MCM-bound chromatin in response to replication stress, revealing a role for FANCI in regulating dormant origin firing independent of ICL repair. |
Super-resolution microscopy, DNA fiber assays, phosphomimetic/phosphodead mutant analysis, siRNA knockdown, chromatin fractionation |
Molecular cell |
High |
25843623
|
| 2015 |
UBE2T (E2 ubiquitin-conjugating enzyme) is necessary for monoubiquitination of both FANCD2 and FANCI; loss of UBE2T abolishes FANCD2 and FANCI monoubiquitination and FANCD2 foci formation, causing Fanconi anemia (FA-T subtype). |
Patient fibroblast complementation, Western blot for monoubiquitination, immunofluorescence for FANCD2 foci, ICL sensitivity assays |
Cell reports |
High |
26119737
|
| 2015 |
FANCI, but not FANCD2, is required for efficient recruitment of the FA core complex to sites of DNA damage (foci formation). This function requires FANCI deubiquitination by USP1 and is independent of FANCI monoubiquitination or ATR-dependent phosphorylation, placing FANCI upstream of FA core complex recruitment independently of FANCD2. |
Immunofluorescence foci assays, siRNA knockdown of FANCI/FANCD2/USP1, cell cycle analysis, epistasis experiments |
PLoS genetics |
Medium |
26430909
|
| 2016 |
The cryo-EM structure of human FANCD2-FANCI complex reveals an inner cavity large enough to accommodate dsDNA and a protruding Tower domain; the complex is recruited to stalled replication forks before monoubiquitination, and this recruitment triggers the activating monoubiquitination event. FA patient mutations in the Tower domain are structurally rationalized. |
Cryo-EM structure determination, cell-based ICL recruitment assays, mutation analysis |
Nature communications |
High |
27405460
|
| 2016 |
The FA core complex contains a homo-dimeric catalytic module (FANCB-FANCL-FAAP100 dimer of trimers) with two FANCL molecules positioned to target both FANCI and FANCD2 for mono-ubiquitination. FANCC-FANCE-FANCF subunits bridge between this module and the FANCI-FANCD2 substrate, transiently altering FANCI-FANCD2 configuration. |
Electron microscopy, crosslink-coupled mass spectrometry, biochemical reconstitution |
Cell reports |
High |
27986592
|
| 2016 |
FANCI-FANCD2 (I-D) complex directly binds RAD51 and stabilizes the RAD51-DNA filament. FANCI DNA binding activity (but not FANCD2) is required for this stabilization. The stabilized RAD51 filament protects DNA ends from FAN1 nucleolytic degradation, explaining how the I-D complex protects stalled replication forks. |
In vitro pulldown and direct binding assays, DNA protection assays with FAN1, FANCI DNA-binding mutant analysis |
Nucleic acids research |
High |
27694619
|
| 2016 |
FANCI forms a novel protein complex with Akt, PHLPP1, PHLPP2, FANCD2, USP1, and UAF1. Depletion of FANCI (but not FANCD2 or USP1) increases Akt phosphorylation/activation by reducing PHLPP1-Akt interaction, defining FANCI as a negative regulator of Akt activation. |
Co-immunoprecipitation, siRNA knockdown, Western blot for phospho-Akt, apoptosis assay |
Cell cycle |
Medium |
27097374
|
| 2017 |
FANCI S/TQ cluster phosphorylation at serines 556, 559, and 565 occurs in two waves: S556 phosphorylation is ubiquitination-independent (upstream), while S559 and S565 phosphorylation is ubiquitination-linked (downstream). Ubiquitination-linked phosphorylation inhibits FANCD2 deubiquitination by USP1 and bypasses the need to deubiquitinate FANCD2 for effective ICL repair. |
Phospho-specific antibodies, ubiquitination-resistant/phosphomimetic mutants, USP1 depletion, ICL repair assays |
Cell reports |
High |
28636932
|
| 2017 |
FANCI and FANCD2 associate with splicing factor SF3B1 (U2 snRNP component). Replication stress induces ATR-dependent release of SF3B1 from nuclear speckles in a FANCI-dependent manner. Both FANCI and FANCD2 associate with SF3B1 on chromatin, prevent accumulation of postcatalytic intron lariats, and contribute to timely eviction of splicing factors. |
Co-immunoprecipitation, proximity ligation assay, immunofluorescence, siRNA knockdown, RNA lariat analysis |
The Journal of cell biology |
Medium |
29030393
|
| 2019 |
FANCI localizes to the nucleolus and functions in ribosome biogenesis independently of FANCD2: it is functionally linked to pre-rRNA transcription and large ribosomal subunit pre-rRNA processing. In the nucleolus, FANCI is predominantly in the deubiquitinated state, requiring both nucleoplasmic (USP1) and nucleolar (USP36) deubiquitinases. |
Immunofluorescence/nucleolar localization, siRNA knockdown, pre-rRNA processing assays, immunoprecipitation |
PNAS |
Medium |
30692263
|
| 2019 |
Human FANCI-FANCD2 (ID2) complex binds single-stranded RNA (ssRNA) and R-loop substrates with high affinity, preferring guanine-rich sequences, by recognizing displaced ssDNA and ssRNA but not the RNA:DNA hybrid. RNA and R-loop substrates strongly stimulate ID2 monoubiquitination in proportion to their binding affinity. |
In vitro binding assays with purified ID2 and synthetic substrates, in vitro monoubiquitination assay, DART assay for in-cell R-loop colocalization |
Cell reports |
High |
30650351
|
| 2019 |
FANCI interacts with FANCD2 via its in vitro binding; mutations in FANCI that impair FANCD2 binding (e.g., FANCD2 L231R equivalent) abolish ID complex formation and FANCD2 monoubiquitination and histone chaperone activity. |
In vitro binding assays with purified chicken FANCD2 L234R mutant, DT40 cell complementation, monoubiquitination assay, nucleosome assembly assay |
PloS one |
Medium |
25489943
|
| 2019 |
FANCI interacts with PIDD1 to enable PIDDosome (PIDD1-RAIDD-caspase-2) assembly and apoptosis as an alternative to ICL repair with FANCD2. FANCI switches from FANCD2/repair to PIDD1/apoptosis when repair fails. Monoubiquitination (K523) and deubiquitination of FANCI impact interactor selection between FANCD2 and PIDD1. |
Co-immunoprecipitation, FANCI knockdown/knockout, caspase-2 activity assays, nuclease deletion epistasis, monoubiquitination site mutation (K523R) |
Developmental cell |
High |
34256011
|
| 2019 |
CK2 phosphorylates a cluster of sites on FANCD2, inhibiting both FANCD2 recruitment to ICLs and its monoubiquitination in vitro and in vivo by reducing FANCD2 DNA binding activity, thereby suppressing FA pathway activation in the absence of damage. |
In vitro kinase assay, in vitro monoubiquitination assay, DNA binding assay, cell-based ICL sensitivity, phosphomimetic/phosphodead mutants |
Cell reports |
High |
31167143
|
| 2020 |
Cryo-EM structures of chicken FANCD2-FANCI reveal that monoubiquitinated FANCD2 causes the complex to adopt a closed conformation that creates a channel enclosing dsDNA. Ubiquitin is positioned at the FANCD2-FANCI interface, acting as a covalent molecular pin to trap the complex on DNA. Unmodified FANCD2 forms a homodimer unable to bind DNA, suggesting autoinhibition. |
Cryo-EM structure determination, biochemical DNA binding assays, ubiquitination state analysis |
Nature structural & molecular biology |
High |
32066963
|
| 2020 |
Reconstituted monoubiquitinated FANCI:FANCD2 does not promote specific exogenous protein-protein interactions but instead stabilizes FANCI:FANCD2 heterodimers on dsDNA (DNA clamping). Only FANCD2 monoubiquitination is required for clamping. Monoubiquitinated FANCI:FANCD2 forms filament-like arrays on long dsDNA. |
In vitro FA pathway reconstitution, electron microscopy, DNA binding assays, biochemical interaction assays |
eLife |
High |
32167469
|
| 2020 |
ATR directly phosphorylates FANCI on S556, S559, and S565 to stabilize its association with DNA and FANCD2, stimulating conjugation of ubiquitin to both FANCI and FANCD2, and inhibiting deubiquitination. S559 and S565 are particularly important for protecting the complex from USP1:UAF1. |
Biochemical reconstitution with recombinant ATR, phosphomimetic/phosphodead FANCI mutants, in vitro ubiquitination/deubiquitination assays |
Frontiers in cell and developmental biology |
High |
32117957
|
| 2020 |
FANCD2 ubiquitination promotes a large-scale conformational change in the ID2 complex increasing affinity for dsDNA by forming a secondary 'Arm' ID2 interface that encircles DNA. FANCI ubiquitination protects ubiquitin on FANCD2 from USP1-UAF1 deubiquitination, with key hydrophobic residues of FANCI's ubiquitin being important for this protection. |
Cryo-EM, biochemical deubiquitination assays with USP1-UAF1, DNA binding assays, ubiquitin mutant analysis |
EMBO reports |
High |
32510829
|
| 2021 |
FANCI is required for spermatogenesis; FANCI deletion in mice causes male sterility with germ cell apoptosis and loss of undifferentiated spermatogonia. FANCI colocalizes with RPA on meiotic chromosomes, interacts with RAD51, and stimulates D-loop formation (unlike FANCD2), revealing a meiotic recombination function of FANCI independent of FANCD2. |
Fanci conditional knockout mouse model, meiotic chromosome immunofluorescence, D-loop assay, Co-IP with RAD51 |
Cell death & disease |
Medium |
31219578 34373449
|
| 2022 |
Cryo-EM structures of FANCD2-FANCI with phosphomimetic FANCI show that phosphorylation destabilizes the open state and causes the complex to close around DNA independently of the FA core complex, priming the complex for ubiquitination. Phosphomimetic mutations do not substantially alter DNA binding but alter conformational dynamics. |
Cryo-EM structure determination with phosphomimetic FANCI, DNA binding assays, conformational dynamics analysis |
Nature structural & molecular biology |
High |
36050501
|
| 2022 |
Cryo-EM structure of FANCI-ubiquitinated (IUb D2) complex shows it adopts the closed, DNA-encircling conformation with FANCD2 target lysine K561 exposed/primed for re-ubiquitination. FANCI ubiquitination maintains FANCD2 ubiquitination by both preventing deubiquitination within IUb D2Ub-DNA and enabling re-ubiquitination of FANCD2 within an IUb D2-DNA complex. |
Cryo-EM (4.1 Å structure), in vitro ubiquitination/deubiquitination assays, DNA binding assays |
The EMBO journal |
High |
36385258
|
| 2024 |
Single-molecule imaging shows FANCD2-FANCI is a sliding clamp that diffuses on dsDNA and stalls specifically at ssDNA-dsDNA junctions (present at stalled replication forks). Cryo-EM structures of stalled D2-I show specific contacts with the ss-dsDNA junction distinct from sliding interactions, providing a unified mechanism for recognition and protection of stalled replication forks. |
Single-molecule TIRF imaging, cryo-EM structure determination on DNA substrates |
Nature |
High |
39085614
|
| 2024 |
PP2A phosphatase complex specifically dephosphorylates an inhibitory cluster in FANCD2, licensing FANCD2/FANCI complex loading onto chromosomes and enabling monoubiquitination. In vitro reconstitution of coupled dephosphorylation-ubiquitination was achieved. Super-resolution live-cell imaging shows PP2A switches on the FA pathway at ICLs. |
In vitro reconstitution of PP2A dephosphorylation coupled to ubiquitination, super-resolution single-molecule live-cell tracking, PP2A inhibitor/knockdown experiments |
Cell reports |
High |
39535917
|
| 2024 |
SRSF1 physically interacts with FANCD2 and acts together to suppress R-loop formation via mRNA export regulation. SRSF1 stimulates FANCD2 monoubiquitination in an RNA-dependent fashion; FANCD2 monoubiquitination is required for assembly of the SRSF1-NXF1 nuclear export complex and mRNA export. Cancer-associated SRSF1 mutants fail to interact with FANCD2, leading to defective monoubiquitination and R-loop accumulation. |
Co-immunoprecipitation, monoubiquitination assays, mRNA export assays, R-loop assays, SRSF1 mutant analysis |
Cell reports |
Medium |
38165804
|
| 2010 |
FANCI patient-derived C-terminal mutant R1299X (deletion of 30 C-terminal residues) mislocalizes in cells. Within this 30-aa stretch are separable functional elements: a nuclear localization signal essential for nuclear targeting and robust FANCD2 monoubiquitination, and a putative EDGE motif important for DNA crosslink repair independent of localization. |
Patient-derived mutant analysis, immunofluorescence localization, complementation assays, ICL sensitivity |
Blood |
Medium |
20971953
|
| 2010 |
In C. elegans, FANCI ortholog is required for FANCD2 focus formation and ubiquitination after ICL damage. FANCM and FANCI act upstream of FANCD2 activation in an ATR-CHK1-dependent pathway, establishing conservation of this signaling axis. |
Genetic epistasis in C. elegans, immunofluorescence foci assays, ubiquitination analysis, RNAi knockdown |
DNA repair |
Medium |
20075016
|
| 2019 |
CTDP1 (a phosphatase with BRCT domain) interacts with FANCI and regulates multiple aspects of FANCI activity including chromatin localization, interaction with γ-H2AX, and SQ motif phosphorylations. CTDP1 knockdown reduces FANCI chromatin localization and impairs ICL repair. |
Co-immunoprecipitation, chromatin fractionation, phosphorylation assays, siRNA knockdown, ICL sensitivity assays |
Cell death discovery |
Low |
31240132
|
| 2018 |
BRMS1 interacts with FANCI via BRMS1's linker region between two coiled-coil motifs. BRMS1 knockdown/knockout reduces FANCI and FANCD2 monoubiquitination and FANCD2 foci formation in response to ICL damage. BRMS1-FANCI interaction is required for BRMS1's regulatory role in the FA pathway. |
Co-immunoprecipitation, siRNA/CRISPR knockout, monoubiquitination Western blot, FANCD2 foci assays, rescue with BRMS1 deletion constructs |
Oncology reports |
Low |
30365131
|